Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Conversion to Open Surgery × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 1

Interventions

Docetaxel 68 pembrolizumab 48 Prednisone 43 Nivolumab 40 enzalutamide 36 Sunitinib 36 Gemcitabine 36 Cyclophosphamide 29 Radiotherapy 25 Leuprolide 25 Abiraterone Acetate 25 Magnetic Resonance Spectroscopy 24 Sorafenib 23 Everolimus 23 Cisplatin 23 bicalutamide 19 atezolizumab 18 Carboplatin 18 avelumab 17 Radiosurgery 17 Goserelin 17 Bevacizumab 17 Interleukin-2 16 abiraterone 15 fludarabine 14 Doxorubicin 14 olaparib 13 durvalumab 13 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 13 Radiotherapy, Intensity-Modulated 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03849820 2025-06-17

OpeRa

Intuitive Surgical

Phase NA Terminated

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡